PRAVASISAMWAD.COM
The World Bank has announced additional funding of $8 billion for Covid-19 vaccines, for developing countries. The total financing now reaches $20 billion.
With the aim to support affordable and equitable vaccine acquisition and deployment, and to let potential suppliers know that the Bank financing is available to its clients, the World Bank has announced additional funding of $8 billion for Covid-19 vaccines, for developing countries. The total financing now reaches $20 billion. To be used till 2022 end, the World Bank Group President David Malpass has requested vaccine manufacturers to prioritise the available doses for such developing countries that urgently need them, half of which are in Africa. As of July 1, 2021, the World Bank approved operations to support vaccine rollout in 53 countries, amounting to $4.4 billion.
Through this, the World Bank Group is working with partners on the largest vaccination effort in history to stop the COVID-19 pandemic.
To support affordable and equitable vaccine acquisition and deployment, and to let potential suppliers know that the Bank financing is available to its clients, the World Bank has announced additional funding of $8 billion for Covid-19 vaccines, for developing countries.
The World Bank’s rapid mobilization of vaccine financing aims to support affordable and equitable vaccine acquisition and deployment and to signal to potential suppliers that Bank financing is available to its clients. It is working in global solidarity with COVAX, WHO, UNICEF and other partners at global and country levels to support IDA and IBRD countries. This financing can be used by countries to make payments to COVAX, including the purchase of additional doses beyond the COVAX-provided 20% as countries aim for higher levels of coverage.
The World Bank has always supported large scale immunization programs for vaccine preventable diseases, as well as public health programs to tackle infectious diseases such as HIV, tuberculosis, malaria and neglected tropical diseases.